SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Brain Serotonin Function in MDMA (Ecstasy) Users: Evidence for Persisting Neurotoxicity
3 references·1 citing·17 second hop
Brain Serotonin Function in MDMA (Ecstasy) Users: Evidence for Persisting Neurotoxicity (2012)Brain Serotonin Function in MDMA (Ecstasy…Evidence for Chronically Altered Serotonin Function in the Cerebral Cortex of Female 3,4-Methylenedioxymethamphetamine Polydrug Users (2011)Evidence for Chronically Alte…Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[11C]DASB and structural brain imaging study (2010)Decreased cerebral cortical s…Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (±)3,4-methylenedioxymethamphetamine (“ecstasy”) users: relationship to cognitive performance (2008)Positron emission tomographic…The Potential Dangers of Using MDMA for Psychotherapy (2014)The Potential Dangers of Usin…A Simple Objective Technique for Measuring Flexibility in Thinking (1948)The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation (1993)Structured clinical interview for DSM-IV axis I disorders : SCID-I : clinical version : scoresheet (1997)Sustained Recreational Use of Ecstasy Is Associated with Altered Pre and Postsynaptic Markers of Serotonin Transmission in Neocortical Areas: A PET Study with [11C]DASB and [11C]MDL 100907 (2012)MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational ‘Ecstasy’ users (2013)Subjective Reports of the Effects of MDMA in a Clinical Setting (1986)Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers (1998)The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) (2003)Psychedelics and Psychedelic-Assisted Psychotherapy (2020)VALIDITY OF THE TRAIL MAKING TEST AS AN INDICATOR OF ORGANIC BRAIN DAMAGE (1958)A RATING SCALE FOR DEPRESSION (1960)A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale (1991)3,4-methylenedioxymethamphetamine (MDMA): current perspectives (2013)Neuroimaging of reward mechanisms in Gambling disorder: an integrative review (2018)An Inventory for Measuring Depression (1961)The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 (1998)Neuroimaging in moderate MDMA use: A systematic review (2015)
this work references cited by second hop

References

  • 2010Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[11C]DASB and structural brain imaging study172 cited
  • 2008Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (±)3,4-methylenedioxymethamphetamine (“ecstasy”) users: relationship to cognitive performance149 cited
  • 2011Evidence for Chronically Altered Serotonin Function in the Cerebral Cortex of Female 3,4-Methylenedioxymethamphetamine Polydrug Users70 cited

Cited by

  • 2014The Potential Dangers of Using MDMA for Psychotherapy60 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work